Environmental

No disclosed R&D intensity in the provided metrics limits evidence of environmental innovation relative to peers, leaving the company neither clearly advantaged nor disadvantaged.

The absence of reported environmental operating metrics prevents a peer-based assessment of emissions, resource use, or transition exposure, which keeps the environmental profile neutral.

Compared with peers that disclose climate or resource-management data, the available dataset offers less transparency, but this is an information gap rather than a demonstrated ESG weakness.

Social

Stock-based compensation at 3.6% of revenue suggests some alignment incentives, but the level is not enough to indicate a clear peer-leading workforce or retention advantage.

The provided data do not show employee safety, turnover, or product-responsibility metrics, so social positioning cannot be distinguished from peers on disclosed evidence.

Relative to peers with broader human-capital disclosure, the limited dataset constrains confidence in social oversight, keeping the score in the middle range.

Governance

Negative debt-to-equity and net-debt-to-EBITDA values indicate a conservative balance-sheet structure, which generally reduces creditor pressure and supports governance resilience versus leveraged peers.

Stock-based compensation at 3.6% of revenue is a manageable dilution signal, but without board or audit disclosures it does not establish a stronger governance profile than peers.

The lack of provided controversy, restatement, or control-failure indicators avoids a structural governance penalty, yet disclosure depth remains thinner than for better-governed peers.

Overall Score

MEDS appears broadly middle-of-pack on ESG versus peers because the available data show no major structural weakness, but disclosure depth is too limited to support a stronger relative score.

Score Driver: Limited ESG Disclosure Across Environmental And Social Metrics Is The Main Constraint On Relative Positioning.